Related Experiment Video

Updated: Nov 5, 2025

Assessment of Kidney Function in Mouse Models of Glomerular Disease
09:16

Assessment of Kidney Function in Mouse Models of Glomerular Disease

Published on: June 30, 2018

18.1K

A clinical approach to children with C3 glomerulopathy

Marina Vivarelli1, Nicole van de Kar2, Raffaella Labbadia3

  • 1Division of Nephrology and Dialysis, Department of Pediatric Subspecialties, Bambino Gesù Pediatric Hospital IRCCS, Piazza S Onofrio 4, 00165, Rome, Italy. marina.vivarelli@opbg.net.

Pediatric Nephrology (Berlin, Germany)
|May 18, 2021
PubMed

Insights

C3 glomerulopathy diagnosis and treatment are challenging. Understanding complement dysregulation is key, with new oral complement inhibitors offering therapeutic potential for C3 glomerulopathy and other glomerular diseases.

Area of Science:

  • Nephrology
  • Immunology
  • Complement System Biology

Background:

  • C3 glomerulopathy presents diagnostic and therapeutic challenges.
  • Understanding complement dysregulation is crucial for patient care.
  • Emerging oral complement inhibitors offer new treatment avenues.

Purpose of the Study:

  • To review current knowledge and future perspectives on C3 glomerulopathy diagnosis and management.
  • To elucidate the role of complement in C3 glomerulopathy and other glomerular diseases.
  • To provide an overview of ongoing complement inhibitor trials in glomerular diseases.

Main Methods:

  • Literature review of C3 glomerulopathy and related glomerular diseases.
  • Analysis of recent advances in complement pathway research.
  • Summary of ongoing clinical trials for complement inhibitors.

Main Results:

  • Recent research clarifies complement's role in C3 glomerulopathy, IC-MPGN, ANCA-vasculitis, IgA nephropathy, and IgA nephropathy.
  • New oral complement inhibitors are under investigation.
  • Clinical trials are evaluating complement inhibitors in adult and adolescent populations.

Conclusions:

  • A comprehensive understanding of complement dysregulation is vital for managing C3 glomerulopathy.
  • Complement inhibitors show promise for treating various glomerular diseases.
  • Ongoing research and clinical trials are advancing therapeutic strategies.

Keywords:
C3 glomerulopathyChildrenComplementGlomerular disease

More Related Videos

Endoscopic Approach for Colloid Cyst Resection02:30

Endoscopic Approach for Colloid Cyst Resection

Published on: May 23, 2025

348
An Efficient Sieving Method to Isolate Intact Glomeruli from Adult Rat Kidney10:14

An Efficient Sieving Method to Isolate Intact Glomeruli from Adult Rat Kidney

Published on: November 1, 2018

14.1K

Related Concept Videos

Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
168
Angle Closure Glaucoma: Treatment01:28

Angle Closure Glaucoma: Treatment

Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
918
Nephrotic Syndrome II : Assessment and Medical Management01:26

Nephrotic Syndrome II : Assessment and Medical Management

IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document...
52
Nephrotic Syndrome III : Nursing Management01:24

Nephrotic Syndrome III : Nursing Management

Nursing management for nephrotic syndrome adapts as the disease progresses, with strategies evolving to address advancing symptoms and complications.Early-Stage Management In the early stages, nursing interventions for nephrotic syndrome resemble those used in managing acute glomerulonephritis, focusing on symptom monitoring, fluid balance, and managing mild to moderate edema.Vital Signs: Regularly monitor blood pressure, pulse, respiratory rate, and temperature to promptly identify...
96
Acute Kidney Injury III: Clinical Manifestations01:29

Acute Kidney Injury III: Clinical Manifestations

Acute Kidney Injury (AKI) progresses through distinct clinical phases: the oliguric, diuretic, and recovery phases, each marked by unique manifestations and challenges.Oliguric Phase:The oliguric phase is the initial stage of AKI, typically lasting 10 to 14 days. This phase is marked by a significant reduction in urine output, usually less than 400 mL per day, indicating decreased kidney function. Fluid retention is a prominent feature, leading to symptoms such as edema, hypertension, and...
375
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
238